Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
New MM patients with high levels of circulating tumour cells distinguished by in...
Dr Cathelijne Fokkema - Erasmus MC Cancer Institute, Rotterdam, Netherlands
New MM patients with high levels of circulating tumour cells distinguished by increased bone marrow plasma cell proliferation ( Dr Cathelijne Fokkema - Erasmus MC Cancer Institute, Rotterdam, Netherlands )
21 Sep 2021
PARP inhibitors in prostate cancer: Case based testing and clinical decisions
Dr Neal Shore and Prof Fred Saad
PARP inhibitors in prostate cancer: Case based testing and clinical decisions ( Dr Neal Shore and Prof Fred Saad )
20 Sep 2021
Should every transplant eligible NDMM patient receive a transplant?
Prof Morie Gertz - Mayo Clinic, Rochester, USA
Should every transplant eligible NDMM patient receive a transplant? ( Prof Morie Gertz - Mayo Clinic, Rochester, USA )
14 Sep 2021
Culture, Community and Communication in Advanced Disease in India
Dr Dwai Banerjee - Massachusetts Institute of Technology, Boston, USA
Culture, Community and Communication in Advanced Disease in India ( Dr Dwai Banerjee - Massachusetts Institute of Technology, Boston, USA )
26 Aug 2021
Current state of prostate cancer in Antigua and Barbuda
Dr Adrian Rhudd - Mount St. John’s Medical Centre, Antigua, Antigua and Barbuda
Current state of prostate cancer in Antigua and Barbuda ( Dr Adrian Rhudd - Mount St. John’s Medical Centre, Antigua, Antigua and Barbuda )
18 Aug 2021
Part 1: When to test
PARP inhibition in the treatment of prostate cancer
Part 1: When to test ( PARP inhibition in the treatment of prostate cancer )
23 Jul 2021
Part 2: Who to test
PARP inhibition in the treatment of prostate cancer
Part 2: Who to test ( PARP inhibition in the treatment of prostate cancer )
23 Jul 2021
The role of testing in prostate cancer treatment
Prof Phil Cornford, Dr Joaquin Mateo, Prof Alex Wyatt and Prof Derya Tilki
The role of testing in prostate cancer treatment ( Prof Phil Cornford, Dr Joaquin Mateo, Prof Alex Wyatt and Prof Derya Tilki )
20 Jul 2021
Prostate cancer screening using prostate-specific antigen, a multiplex blood-tes...
Prof Martin Eklund - Karolinska Institutet, Solna, Sweden
Prostate cancer screening using prostate-specific antigen, a multiplex blood-test, MRI and targeted prostate biopsies ( Prof Martin Eklund - Karolinska Institutet, Solna, Sweden )
20 Jul 2021
Clinically sufficient vitamin D levels at breast cancer diagnosis and survival o...
Prof Song Yao - Roswell Park Comprehensive Cancer Center, Buffalo, USA
Clinically sufficient vitamin D levels at breast cancer diagnosis and survival outcomes ( Prof Song Yao - Roswell Park Comprehensive Cancer Center, Buffalo, USA )
10 Jun 2021
CodeBreaK100: Sotorasib in pretreated KRAS p.G12C mNSCLC
Dr Ferdinandos Skoulidis - MD Anderson Cancer Center, Houston, USA
CodeBreaK100: Sotorasib in pretreated KRAS p.G12C mNSCLC ( Dr Ferdinandos Skoulidis - MD Anderson Cancer Center, Houston, USA )
9 Jun 2021
LEAP-004: Lenvatinib + pembrolizumab for patients with advanced melanoma and con...
Dr Ana Arance - Hospital Clínic de Barcelona, Barcelona, Spain
LEAP-004: Lenvatinib + pembrolizumab for patients with advanced melanoma and confirmed progression on a PD-1 or PD-L1 inhibitor ( Dr Ana Arance - Hospital Clínic de Barcelona, Barcelona, Spain )
8 Jun 2021